nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS3—glaucoma	0.624	1	CbGaD
L-Arginine—SLC22A4—Clonidine—glaucoma	0.128	0.639	CbGbCtD
L-Arginine—SLC22A5—Clonidine—glaucoma	0.0725	0.361	CbGbCtD
L-Arginine—Necrosis—Carbachol—glaucoma	0.00325	0.0338	CcSEcCtD
L-Arginine—Paraesthesia oral—Brinzolamide—glaucoma	0.0032	0.0333	CcSEcCtD
L-Arginine—Extravasation—Carbachol—glaucoma	0.00292	0.0304	CcSEcCtD
L-Arginine—Rash macular—Clonidine—glaucoma	0.00281	0.0292	CcSEcCtD
L-Arginine—Numbness—Acetazolamide—glaucoma	0.00201	0.0209	CcSEcCtD
L-Arginine—Sensory loss—Acetazolamide—glaucoma	0.00192	0.02	CcSEcCtD
L-Arginine—Lethargy—Levobunolol—glaucoma	0.00186	0.0194	CcSEcCtD
L-Arginine—Tachycardia—Dipivefrin—glaucoma	0.00178	0.0185	CcSEcCtD
L-Arginine—Sweating—Carbachol—glaucoma	0.00137	0.0142	CcSEcCtD
L-Arginine—Vomiting—Physostigmine—glaucoma	0.00136	0.0142	CcSEcCtD
L-Arginine—NOS3—eNOS activation—CAV1—glaucoma	0.00135	0.0175	CbGpPWpGaD
L-Arginine—Hypersensitivity—Dipivefrin—glaucoma	0.00134	0.014	CcSEcCtD
L-Arginine—Swelling—Brimonidine—glaucoma	0.00131	0.0137	CcSEcCtD
L-Arginine—Haematuria—Methazolamide—glaucoma	0.00128	0.0134	CcSEcCtD
L-Arginine—Nausea—Physostigmine—glaucoma	0.00127	0.0132	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—NTF4—glaucoma	0.00126	0.0163	CbGpPWpGaD
L-Arginine—Numbness—Betaxolol—glaucoma	0.00121	0.0126	CcSEcCtD
L-Arginine—Flushing—Carbachol—glaucoma	0.00119	0.0124	CcSEcCtD
L-Arginine—Lethargy—Brimonidine—glaucoma	0.00118	0.0123	CcSEcCtD
L-Arginine—L-Citrulline—NOS3—glaucoma	0.00117	0.594	CrCbGaD
L-Arginine—Sensory loss—Betaxolol—glaucoma	0.00116	0.0121	CcSEcCtD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00107	0.0138	CbGpPWpGaD
L-Arginine—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A4—glaucoma	0.00103	0.0133	CbGpPWpGaD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000998	0.0129	CbGpPWpGaD
L-Arginine—Anorexia—Diclofenamide—glaucoma	0.000888	0.00925	CcSEcCtD
L-Arginine—Haematuria—Acetazolamide—glaucoma	0.000887	0.00925	CcSEcCtD
L-Arginine—Hyperhidrosis—Carbachol—glaucoma	0.000879	0.00916	CcSEcCtD
L-Arginine—Anaphylactic shock—Methazolamide—glaucoma	0.000858	0.00894	CcSEcCtD
L-Arginine—Lethargy—Clonidine—glaucoma	0.000853	0.00888	CcSEcCtD
L-Arginine—Hypoaesthesia—Acetazolamide—glaucoma	0.000831	0.00866	CcSEcCtD
L-Arginine—Sweating—Dorzolamide—glaucoma	0.000818	0.00852	CcSEcCtD
L-Arginine—Anorexia—Methazolamide—glaucoma	0.000817	0.00852	CcSEcCtD
L-Arginine—Decreased appetite—Diclofenamide—glaucoma	0.00081	0.00844	CcSEcCtD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000808	0.0104	CbGpPWpGaD
L-Arginine—L-Methionine—MTHFR—glaucoma	0.000798	0.406	CrCbGaD
L-Arginine—Flushing—Acetazolamide—glaucoma	0.000775	0.00808	CcSEcCtD
L-Arginine—Sweating—Pilocarpine—glaucoma	0.000773	0.00805	CcSEcCtD
L-Arginine—Haematuria—Pilocarpine—glaucoma	0.000769	0.00801	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—NCK2—glaucoma	0.00076	0.0098	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CA5A—glaucoma	0.000755	0.00974	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—NARFL—glaucoma	0.000755	0.00974	CbGpPWpGaD
L-Arginine—Hypersensitivity—Metipranolol—glaucoma	0.000753	0.00785	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000751	0.00969	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Brinzolamide—glaucoma	0.000749	0.00781	CcSEcCtD
L-Arginine—Decreased appetite—Methazolamide—glaucoma	0.000746	0.00777	CcSEcCtD
L-Arginine—NOS3—Metabolism of nitric oxide—CAV1—glaucoma	0.000745	0.00961	CbGpPWpGaD
L-Arginine—Flushing—Brimonidine—glaucoma	0.000744	0.00775	CcSEcCtD
L-Arginine—Lethargy—Betaxolol—glaucoma	0.000742	0.00773	CcSEcCtD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—FN1—glaucoma	0.000733	0.00946	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Pilocarpine—glaucoma	0.00072	0.0075	CcSEcCtD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000716	0.00924	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—TGFB2—glaucoma	0.000699	0.00902	CbGpPWpGaD
L-Arginine—Hypersensitivity—Carteolol—glaucoma	0.000698	0.00727	CcSEcCtD
L-Arginine—ASL—Metabolism—CA5A—glaucoma	0.00069	0.00891	CbGpPWpGaD
L-Arginine—ASL—Metabolism—NARFL—glaucoma	0.00069	0.00891	CbGpPWpGaD
L-Arginine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000686	0.00885	CbGpPWpGaD
L-Arginine—Flushing—Pilocarpine—glaucoma	0.000672	0.007	CcSEcCtD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000666	0.00859	CbGpPWpGaD
L-Arginine—Hypersensitivity—Levobunolol—glaucoma	0.00066	0.00687	CcSEcCtD
L-Arginine—Rash—Metipranolol—glaucoma	0.000645	0.00672	CcSEcCtD
L-Arginine—Dermatitis—Metipranolol—glaucoma	0.000644	0.00671	CcSEcCtD
L-Arginine—Headache—Metipranolol—glaucoma	0.000641	0.00668	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—C1QB—glaucoma	0.00062	0.008	CbGpPWpGaD
L-Arginine—Sweating—Clonidine—glaucoma	0.000617	0.00643	CcSEcCtD
L-Arginine—Nausea—Metipranolol—glaucoma	0.000607	0.00633	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—OPN4—glaucoma	0.000603	0.00778	CbGpPWpGaD
L-Arginine—NOS2—Nitric oxide stimulates guanylate cyclase—NOS3—glaucoma	0.000602	0.00776	CbGpPWpGaD
L-Arginine—NOS3—Endothelin Pathways—EDN1—glaucoma	0.000594	0.00767	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Acetazolamide—glaucoma	0.000594	0.00619	CcSEcCtD
L-Arginine—Headache—Carteolol—glaucoma	0.000594	0.00618	CcSEcCtD
L-Arginine—Vomiting—Diclofenamide—glaucoma	0.000592	0.00617	CcSEcCtD
L-Arginine—Rash—Diclofenamide—glaucoma	0.000587	0.00612	CcSEcCtD
L-Arginine—Headache—Diclofenamide—glaucoma	0.000583	0.00608	CcSEcCtD
L-Arginine—Vomiting—Carbachol—glaucoma	0.000578	0.00602	CcSEcCtD
L-Arginine—Hypoaesthesia—Clonidine—glaucoma	0.000575	0.00599	CcSEcCtD
L-Arginine—Rash—Carbachol—glaucoma	0.000573	0.00597	CcSEcCtD
L-Arginine—Dermatitis—Carbachol—glaucoma	0.000573	0.00597	CcSEcCtD
L-Arginine—ARG2—Metabolism—CA5A—glaucoma	0.000572	0.00738	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—NARFL—glaucoma	0.000572	0.00738	CbGpPWpGaD
L-Arginine—Headache—Carbachol—glaucoma	0.00057	0.00593	CcSEcCtD
L-Arginine—Nausea—Carteolol—glaucoma	0.000563	0.00586	CcSEcCtD
L-Arginine—Headache—Levobunolol—glaucoma	0.000561	0.00584	CcSEcCtD
L-Arginine—Tachycardia—Brimonidine—glaucoma	0.000556	0.00579	CcSEcCtD
L-Arginine—Nausea—Diclofenamide—glaucoma	0.000553	0.00576	CcSEcCtD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000548	0.00707	CbGpPWpGaD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—CAV1—glaucoma	0.000546	0.00705	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000545	0.00704	CbGpPWpGaD
L-Arginine—Vomiting—Methazolamide—glaucoma	0.000545	0.00568	CcSEcCtD
L-Arginine—Anaphylactic shock—Dorzolamide—glaucoma	0.000544	0.00567	CcSEcCtD
L-Arginine—Rash—Methazolamide—glaucoma	0.000541	0.00563	CcSEcCtD
L-Arginine—Dermatitis—Methazolamide—glaucoma	0.00054	0.00563	CcSEcCtD
L-Arginine—Nausea—Carbachol—glaucoma	0.00054	0.00563	CcSEcCtD
L-Arginine—Sweating—Betaxolol—glaucoma	0.000537	0.0056	CcSEcCtD
L-Arginine—Headache—Methazolamide—glaucoma	0.000537	0.0056	CcSEcCtD
L-Arginine—Nausea—Levobunolol—glaucoma	0.000532	0.00554	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—CAV1—glaucoma	0.000531	0.00685	CbGpPWpGaD
L-Arginine—Tachycardia—Travoprost—glaucoma	0.000529	0.00551	CcSEcCtD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—NCK2—glaucoma	0.000529	0.00682	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Dorzolamide—glaucoma	0.000526	0.00548	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—NTRK2—glaucoma	0.000525	0.00678	CbGpPWpGaD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000524	0.00676	CbGpPWpGaD
L-Arginine—Rash—Latanoprost—glaucoma	0.000523	0.00545	CcSEcCtD
L-Arginine—Dermatitis—Latanoprost—glaucoma	0.000523	0.00545	CcSEcCtD
L-Arginine—Tachycardia—Brinzolamide—glaucoma	0.000522	0.00544	CcSEcCtD
L-Arginine—Headache—Latanoprost—glaucoma	0.00052	0.00542	CcSEcCtD
L-Arginine—Anorexia—Dorzolamide—glaucoma	0.000519	0.0054	CcSEcCtD
L-Arginine—Decreased appetite—Acetazolamide—glaucoma	0.000516	0.00538	CcSEcCtD
L-Arginine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000516	0.00665	CbGpPWpGaD
L-Arginine—Nausea—Methazolamide—glaucoma	0.000509	0.00531	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000507	0.00654	CbGpPWpGaD
L-Arginine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000502	0.00648	CbGpPWpGaD
L-Arginine—Tachycardia—Pilocarpine—glaucoma	0.000502	0.00523	CcSEcCtD
L-Arginine—Hypoaesthesia—Betaxolol—glaucoma	0.000501	0.00522	CcSEcCtD
L-Arginine—NOS3—Signaling by VEGF—NCK2—glaucoma	0.000499	0.00644	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Pilocarpine—glaucoma	0.000497	0.00518	CcSEcCtD
L-Arginine—Anorexia—Pilocarpine—glaucoma	0.00049	0.00511	CcSEcCtD
L-Arginine—Hypersensitivity—Apraclonidine—glaucoma	0.000489	0.00509	CcSEcCtD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000487	0.00629	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—SOD1—glaucoma	0.000485	0.00625	CbGpPWpGaD
L-Arginine—Decreased appetite—Dorzolamide—glaucoma	0.000473	0.00493	CcSEcCtD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000467	0.00603	CbGpPWpGaD
L-Arginine—Flushing—Betaxolol—glaucoma	0.000467	0.00487	CcSEcCtD
L-Arginine—Decreased appetite—Brinzolamide—glaucoma	0.000465	0.00485	CcSEcCtD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—CAV2—glaucoma	0.000461	0.00594	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00046	0.00593	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—glaucoma	0.000456	0.00588	CbGpPWpGaD
L-Arginine—NOS2—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—glaucoma	0.000455	0.00588	CbGpPWpGaD
L-Arginine—Decreased appetite—Pilocarpine—glaucoma	0.000447	0.00466	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.00044	0.00567	CbGpPWpGaD
L-Arginine—Sweating—Timolol—glaucoma	0.000439	0.00457	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—NTRK1—glaucoma	0.000428	0.00552	CbGpPWpGaD
L-Arginine—Vomiting—Apraclonidine—glaucoma	0.000422	0.0044	CcSEcCtD
L-Arginine—Hypersensitivity—Brimonidine—glaucoma	0.00042	0.00437	CcSEcCtD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—VEGFA—glaucoma	0.00042	0.00541	CbGpPWpGaD
L-Arginine—Dermatitis—Apraclonidine—glaucoma	0.000418	0.00436	CcSEcCtD
L-Arginine—Headache—Apraclonidine—glaucoma	0.000416	0.00433	CcSEcCtD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.000407	0.00525	CbGpPWpGaD
L-Arginine—Rash—Bimatoprost—glaucoma	0.000406	0.00423	CcSEcCtD
L-Arginine—Dermatitis—Bimatoprost—glaucoma	0.000405	0.00422	CcSEcCtD
L-Arginine—Headache—Bimatoprost—glaucoma	0.000403	0.0042	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—BCL2L1—glaucoma	0.000402	0.00519	CbGpPWpGaD
L-Arginine—Hypersensitivity—Dorzolamide—glaucoma	0.000401	0.00418	CcSEcCtD
L-Arginine—Tachycardia—Clonidine—glaucoma	0.000401	0.00418	CcSEcCtD
L-Arginine—Hypersensitivity—Travoprost—glaucoma	0.000399	0.00416	CcSEcCtD
L-Arginine—Hyperhidrosis—Clonidine—glaucoma	0.000397	0.00414	CcSEcCtD
L-Arginine—ASS1—Metabolism—CA5A—glaucoma	0.000396	0.00511	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NARFL—glaucoma	0.000396	0.00511	CbGpPWpGaD
L-Arginine—Nausea—Apraclonidine—glaucoma	0.000394	0.00411	CcSEcCtD
L-Arginine—Hypersensitivity—Brinzolamide—glaucoma	0.000394	0.00411	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—BDNF—glaucoma	0.000392	0.00506	CbGpPWpGaD
L-Arginine—Anorexia—Clonidine—glaucoma	0.000391	0.00408	CcSEcCtD
L-Arginine—Nausea—Bimatoprost—glaucoma	0.000382	0.00398	CcSEcCtD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—NCK2—glaucoma	0.000379	0.0049	CbGpPWpGaD
L-Arginine—Hypersensitivity—Pilocarpine—glaucoma	0.000379	0.00395	CcSEcCtD
L-Arginine—Vomiting—Acetazolamide—glaucoma	0.000377	0.00393	CcSEcCtD
L-Arginine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000377	0.00487	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—SOD1—glaucoma	0.000376	0.00485	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—MMP9—glaucoma	0.000375	0.00484	CbGpPWpGaD
L-Arginine—Headache—Acetazolamide—glaucoma	0.000372	0.00387	CcSEcCtD
L-Arginine—AZIN2—Metabolism—CA1—glaucoma	0.000369	0.00476	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000364	0.0047	CbGpPWpGaD
L-Arginine—Rash—Brimonidine—glaucoma	0.000359	0.00374	CcSEcCtD
L-Arginine—Dermatitis—Brimonidine—glaucoma	0.000359	0.00374	CcSEcCtD
L-Arginine—AZIN2—Metabolism—CTSA—glaucoma	0.000357	0.00461	CbGpPWpGaD
L-Arginine—Headache—Brimonidine—glaucoma	0.000357	0.00372	CcSEcCtD
L-Arginine—Decreased appetite—Clonidine—glaucoma	0.000357	0.00372	CcSEcCtD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—glaucoma	0.000353	0.00455	CbGpPWpGaD
L-Arginine—Nausea—Acetazolamide—glaucoma	0.000353	0.00367	CcSEcCtD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—PEX19—glaucoma	0.000351	0.00453	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000351	0.00453	CbGpPWpGaD
L-Arginine—Tachycardia—Betaxolol—glaucoma	0.000349	0.00364	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—NGF—glaucoma	0.000348	0.00449	CbGpPWpGaD
L-Arginine—Vomiting—Dorzolamide—glaucoma	0.000346	0.0036	CcSEcCtD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—PEX19—glaucoma	0.000346	0.00446	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Betaxolol—glaucoma	0.000346	0.0036	CcSEcCtD
L-Arginine—Rash—Dorzolamide—glaucoma	0.000343	0.00357	CcSEcCtD
L-Arginine—Dermatitis—Dorzolamide—glaucoma	0.000343	0.00357	CcSEcCtD
L-Arginine—Rash—Travoprost—glaucoma	0.000342	0.00356	CcSEcCtD
L-Arginine—Dermatitis—Travoprost—glaucoma	0.000341	0.00356	CcSEcCtD
L-Arginine—Headache—Dorzolamide—glaucoma	0.000341	0.00355	CcSEcCtD
L-Arginine—Anorexia—Betaxolol—glaucoma	0.000341	0.00355	CcSEcCtD
L-Arginine—Vomiting—Brinzolamide—glaucoma	0.00034	0.00354	CcSEcCtD
L-Arginine—Headache—Travoprost—glaucoma	0.000339	0.00354	CcSEcCtD
L-Arginine—Nausea—Brimonidine—glaucoma	0.000338	0.00353	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000338	0.00437	CbGpPWpGaD
L-Arginine—Rash—Brinzolamide—glaucoma	0.000337	0.00351	CcSEcCtD
L-Arginine—ASL—Metabolism—CA1—glaucoma	0.000337	0.00435	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CA2—glaucoma	0.000337	0.00435	CbGpPWpGaD
L-Arginine—Dermatitis—Brinzolamide—glaucoma	0.000337	0.00351	CcSEcCtD
L-Arginine—NOS3—Angiogenesis—VEGFA—glaucoma	0.000337	0.00434	CbGpPWpGaD
L-Arginine—Headache—Brinzolamide—glaucoma	0.000335	0.00349	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—FN1—glaucoma	0.000333	0.0043	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—BAD—glaucoma	0.000329	0.00425	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—NGFR—glaucoma	0.000329	0.00424	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—FN1—glaucoma	0.000327	0.00422	CbGpPWpGaD
L-Arginine—Vomiting—Pilocarpine—glaucoma	0.000327	0.00341	CcSEcCtD
L-Arginine—ASL—Metabolism—CTSA—glaucoma	0.000326	0.00421	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.000325	0.00419	CbGpPWpGaD
L-Arginine—Rash—Pilocarpine—glaucoma	0.000324	0.00338	CcSEcCtD
L-Arginine—Dermatitis—Pilocarpine—glaucoma	0.000324	0.00337	CcSEcCtD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—glaucoma	0.000323	0.00417	CbGpPWpGaD
L-Arginine—Nausea—Dorzolamide—glaucoma	0.000323	0.00337	CcSEcCtD
L-Arginine—Headache—Pilocarpine—glaucoma	0.000322	0.00336	CcSEcCtD
L-Arginine—Nausea—Travoprost—glaucoma	0.000322	0.00335	CcSEcCtD
L-Arginine—Nausea—Brinzolamide—glaucoma	0.000318	0.00331	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—MMP2—glaucoma	0.000313	0.00404	CbGpPWpGaD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000312	0.00402	CbGpPWpGaD
L-Arginine—Decreased appetite—Betaxolol—glaucoma	0.000311	0.00324	CcSEcCtD
L-Arginine—ASL—Metabolism—CA2—glaucoma	0.000308	0.00398	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000307	0.00396	CbGpPWpGaD
L-Arginine—Nausea—Pilocarpine—glaucoma	0.000305	0.00318	CcSEcCtD
L-Arginine—Hypersensitivity—Clonidine—glaucoma	0.000303	0.00315	CcSEcCtD
L-Arginine—Anaphylactic shock—Timolol—glaucoma	0.000292	0.00304	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—VEGFA—glaucoma	0.000289	0.00373	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—BDNF—glaucoma	0.000286	0.00369	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—MMP2—glaucoma	0.000286	0.00369	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Timolol—glaucoma	0.000282	0.00294	CcSEcCtD
L-Arginine—ARG2—Metabolism—CA1—glaucoma	0.000279	0.0036	CbGpPWpGaD
L-Arginine—Anorexia—Timolol—glaucoma	0.000278	0.0029	CcSEcCtD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—MMP2—glaucoma	0.000277	0.00358	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL1A—glaucoma	0.000275	0.00354	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CTSA—glaucoma	0.000271	0.00349	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—CAV1—glaucoma	0.000269	0.00347	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—NOS3—glaucoma	0.000268	0.00346	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000266	0.00344	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—glaucoma	0.000265	0.00342	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—PEX19—glaucoma	0.000264	0.00341	CbGpPWpGaD
L-Arginine—Hypersensitivity—Betaxolol—glaucoma	0.000263	0.00274	CcSEcCtD
L-Arginine—NOS2—IL23-mediated signaling events—TNF—glaucoma	0.000263	0.00339	CbGpPWpGaD
L-Arginine—Vomiting—Clonidine—glaucoma	0.000261	0.00272	CcSEcCtD
L-Arginine—Rash—Clonidine—glaucoma	0.000259	0.0027	CcSEcCtD
L-Arginine—Dermatitis—Clonidine—glaucoma	0.000259	0.00269	CcSEcCtD
L-Arginine—NOS3—Leptin signaling pathway—BCL2L1—glaucoma	0.000258	0.00333	CbGpPWpGaD
L-Arginine—Headache—Clonidine—glaucoma	0.000257	0.00268	CcSEcCtD
L-Arginine—ARG2—Metabolism—CA2—glaucoma	0.000255	0.0033	CbGpPWpGaD
L-Arginine—Decreased appetite—Timolol—glaucoma	0.000254	0.00265	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000248	0.00319	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.000244	0.00315	CbGpPWpGaD
L-Arginine—Nausea—Clonidine—glaucoma	0.000244	0.00254	CcSEcCtD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000242	0.00313	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—TXN—glaucoma	0.000238	0.00306	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000237	0.00306	CbGpPWpGaD
L-Arginine—NOS2—Platelet homeostasis—NOS3—glaucoma	0.000234	0.00302	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000234	0.00302	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—BAD—glaucoma	0.000234	0.00301	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000234	0.00301	CbGpPWpGaD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000228	0.00294	CbGpPWpGaD
L-Arginine—Vomiting—Betaxolol—glaucoma	0.000227	0.00237	CcSEcCtD
L-Arginine—Rash—Betaxolol—glaucoma	0.000225	0.00235	CcSEcCtD
L-Arginine—Dermatitis—Betaxolol—glaucoma	0.000225	0.00235	CcSEcCtD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000224	0.0029	CbGpPWpGaD
L-Arginine—Headache—Betaxolol—glaucoma	0.000224	0.00233	CcSEcCtD
L-Arginine—NOS3—AGE/RAGE pathway—MMP2—glaucoma	0.000222	0.00286	CbGpPWpGaD
L-Arginine—ASL—Metabolism—TXN—glaucoma	0.000217	0.0028	CbGpPWpGaD
L-Arginine—Hypersensitivity—Timolol—glaucoma	0.000215	0.00224	CcSEcCtD
L-Arginine—NOS2—AGE/RAGE pathway—MMP9—glaucoma	0.000215	0.00277	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—NGFR—glaucoma	0.000215	0.00277	CbGpPWpGaD
L-Arginine—Nausea—Betaxolol—glaucoma	0.000212	0.00221	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—NTRK1—glaucoma	0.000204	0.00263	CbGpPWpGaD
L-Arginine—NOS2—Disease—LRP12—glaucoma	0.000201	0.00259	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CA1—glaucoma	0.000194	0.0025	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000193	0.00249	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CTSA—glaucoma	0.000188	0.00242	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—CAV1—glaucoma	0.000187	0.00241	CbGpPWpGaD
L-Arginine—Vomiting—Timolol—glaucoma	0.000186	0.00193	CcSEcCtD
L-Arginine—AZIN2—Metabolism—GSTT1—glaucoma	0.000184	0.00238	CbGpPWpGaD
L-Arginine—Rash—Timolol—glaucoma	0.000184	0.00192	CcSEcCtD
L-Arginine—Dermatitis—Timolol—glaucoma	0.000184	0.00192	CcSEcCtD
L-Arginine—Headache—Timolol—glaucoma	0.000183	0.00191	CcSEcCtD
L-Arginine—ARG2—Metabolism—TXN—glaucoma	0.00018	0.00232	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000178	0.0023	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CA2—glaucoma	0.000177	0.00228	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—CAV1—glaucoma	0.000176	0.00228	CbGpPWpGaD
L-Arginine—Nausea—Timolol—glaucoma	0.000173	0.00181	CcSEcCtD
L-Arginine—NOS3—Metabolism—CA5A—glaucoma	0.000173	0.00223	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NARFL—glaucoma	0.000173	0.00223	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000172	0.00221	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GSTT1—glaucoma	0.000168	0.00217	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—MMP9—glaucoma	0.000167	0.00215	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—VEGFA—glaucoma	0.000166	0.00214	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—glaucoma	0.00016	0.00207	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—FAS—glaucoma	0.00016	0.00206	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000158	0.00204	CbGpPWpGaD
L-Arginine—NOS3—Disease—LRP12—glaucoma	0.000156	0.00201	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000156	0.00201	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—PTGS2—glaucoma	0.000154	0.00199	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CYP1B1—glaucoma	0.000147	0.00189	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—ABCA1—glaucoma	0.000147	0.00189	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—glaucoma	0.000146	0.00189	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CDKN1B—glaucoma	0.000146	0.00188	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—glaucoma	0.000144	0.00186	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GSTT1—glaucoma	0.00014	0.0018	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—MMP9—glaucoma	0.000135	0.00174	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CYP1B1—glaucoma	0.000134	0.00173	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ABCA1—glaucoma	0.000134	0.00173	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—CAV1—glaucoma	0.000134	0.00173	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGFR1OP—glaucoma	0.00013	0.00167	CbGpPWpGaD
L-Arginine—NOS2—Disease—HEYL—glaucoma	0.00013	0.00167	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TGFB2—glaucoma	0.000125	0.00162	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TXN—glaucoma	0.000125	0.00161	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000119	0.00154	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GSTM1—glaucoma	0.000117	0.00151	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000116	0.0015	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000114	0.00147	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ABCA1—glaucoma	0.000111	0.00143	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CYP1B1—glaucoma	0.000111	0.00143	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—LRP12—glaucoma	0.000109	0.00141	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GSTM1—glaucoma	0.000107	0.00138	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TNF—glaucoma	0.000104	0.00134	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—MTHFR—glaucoma	0.000104	0.00134	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—glaucoma	0.000102	0.00131	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGFR1OP—glaucoma	0.000101	0.0013	CbGpPWpGaD
L-Arginine—NOS3—Disease—HEYL—glaucoma	0.000101	0.0013	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TGFB2—glaucoma	9.73e-05	0.00126	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GSTT1—glaucoma	9.67e-05	0.00125	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—APOE—glaucoma	9.65e-05	0.00125	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—VEGFA—glaucoma	9.61e-05	0.00124	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CAV1—glaucoma	9.56e-05	0.00123	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SOD1—glaucoma	9.5e-05	0.00123	CbGpPWpGaD
L-Arginine—ASL—Metabolism—MTHFR—glaucoma	9.48e-05	0.00122	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—glaucoma	9.16e-05	0.00118	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GSTM1—glaucoma	8.89e-05	0.00115	CbGpPWpGaD
L-Arginine—ASL—Metabolism—APOE—glaucoma	8.83e-05	0.00114	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CAV1—glaucoma	8.75e-05	0.00113	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.72e-05	0.00112	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CA1—glaucoma	8.43e-05	0.00109	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CTSA—glaucoma	8.16e-05	0.00105	CbGpPWpGaD
L-Arginine—NOS2—Disease—HDAC9—glaucoma	8.09e-05	0.00104	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—MTHFR—glaucoma	7.86e-05	0.00101	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CA2—glaucoma	7.71e-05	0.000994	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CYP1B1—glaucoma	7.71e-05	0.000994	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ABCA1—glaucoma	7.71e-05	0.000994	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—OPN4—glaucoma	7.58e-05	0.000978	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SOD1—glaucoma	7.38e-05	0.000952	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—APOE—glaucoma	7.31e-05	0.000944	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CAV1—glaucoma	7.25e-05	0.000935	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MMP1—glaucoma	7.24e-05	0.000935	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—NOS3—glaucoma	7.23e-05	0.000933	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HEYL—glaucoma	7.05e-05	0.000909	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—CAV1—glaucoma	6.95e-05	0.000896	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTGFR—glaucoma	6.82e-05	0.00088	CbGpPWpGaD
L-Arginine—ASL—Metabolism—NOS3—glaucoma	6.61e-05	0.000853	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTGS2—glaucoma	6.61e-05	0.000853	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—FN1—glaucoma	6.61e-05	0.000853	CbGpPWpGaD
L-Arginine—NOS3—Disease—HDAC9—glaucoma	6.28e-05	0.00081	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GSTM1—glaucoma	6.16e-05	0.000795	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—glaucoma	6.05e-05	0.00078	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—glaucoma	5.98e-05	0.000772	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MMP1—glaucoma	5.62e-05	0.000726	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—NOS3—glaucoma	5.48e-05	0.000707	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—MTHFR—glaucoma	5.45e-05	0.000703	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TXN—glaucoma	5.43e-05	0.000701	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—CAV1—glaucoma	5.39e-05	0.000696	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RPTOR—glaucoma	5.34e-05	0.000689	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NOS3—glaucoma	5.25e-05	0.000678	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NCK2—glaucoma	5.17e-05	0.000667	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—FN1—glaucoma	5.13e-05	0.000662	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—APOE—glaucoma	5.07e-05	0.000654	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CAV1—glaucoma	5.02e-05	0.000648	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—glaucoma	5.01e-05	0.000647	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HDAC9—glaucoma	4.4e-05	0.000567	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN2B—glaucoma	4.35e-05	0.000561	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTT1—glaucoma	4.21e-05	0.000543	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NOS3—glaucoma	3.8e-05	0.00049	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—glaucoma	3.78e-05	0.000488	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTHFR—glaucoma	3.65e-05	0.00047	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—glaucoma	3.47e-05	0.000448	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SMO—glaucoma	3.44e-05	0.000444	CbGpPWpGaD
L-Arginine—NOS2—Disease—APOE—glaucoma	3.39e-05	0.000438	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN2B—glaucoma	3.38e-05	0.000436	CbGpPWpGaD
L-Arginine—NOS2—Disease—CAV1—glaucoma	3.36e-05	0.000434	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ABCA1—glaucoma	3.36e-05	0.000433	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP1B1—glaucoma	3.36e-05	0.000433	CbGpPWpGaD
L-Arginine—NOS2—Disease—BAD—glaucoma	3.16e-05	0.000408	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NTRK2—glaucoma	3.15e-05	0.000406	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—glaucoma	2.94e-05	0.000379	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—glaucoma	2.86e-05	0.000369	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTHFR—glaucoma	2.83e-05	0.000365	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NGFR—glaucoma	2.7e-05	0.000348	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTM1—glaucoma	2.68e-05	0.000346	CbGpPWpGaD
L-Arginine—NOS3—Disease—APOE—glaucoma	2.64e-05	0.00034	CbGpPWpGaD
L-Arginine—NOS3—Disease—CAV1—glaucoma	2.61e-05	0.000337	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NTRK1—glaucoma	2.57e-05	0.000331	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOS3—glaucoma	2.54e-05	0.000328	CbGpPWpGaD
L-Arginine—NOS3—Disease—BAD—glaucoma	2.46e-05	0.000317	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—MTHFR—glaucoma	2.37e-05	0.000306	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN2B—glaucoma	2.36e-05	0.000305	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—glaucoma	2.33e-05	0.0003	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EDN1—glaucoma	2.27e-05	0.000293	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—glaucoma	2.22e-05	0.000286	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—APOE—glaucoma	2.21e-05	0.000285	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1B—glaucoma	2.2e-05	0.000284	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CAV1—glaucoma	2.19e-05	0.000282	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NGF—glaucoma	2.08e-05	0.000269	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—C3—glaucoma	1.98e-05	0.000256	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APOE—glaucoma	1.85e-05	0.000238	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CAV1—glaucoma	1.83e-05	0.000236	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—glaucoma	1.81e-05	0.000233	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FN1—glaucoma	1.74e-05	0.000225	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BAD—glaucoma	1.72e-05	0.000222	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1B—glaucoma	1.71e-05	0.000221	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—glaucoma	1.51e-05	0.000195	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1B—glaucoma	1.2e-05	0.000154	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—glaucoma	1.11e-05	0.000143	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—glaucoma	9.96e-06	0.000128	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—glaucoma	7.53e-06	9.71e-05	CbGpPWpGaD
